Bicara Therapeutics Inc. (BCAX) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 42 days, typically, give or take 21 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026before open 40 8-K
Q2 FY2026Tue, Aug 11, 2026before open 42 8-K
Q1 FY2026Mon, May 11, 2026before open 41 8-K
Q4 FY2025Mon, Mar 30, 2026before open 89 8-K
Q3 FY2025Mon, Nov 10, 2025before open 41 8-K
Q2 FY2025Tue, Aug 12, 2025before open 43 8-K
Q1 FY2025Tue, May 13, 2025before open 43 8-K
Q4 FY2024Thu, Mar 27, 2025before open 86 8-K

What they guided beta

Q3 FY2026 "Document Bicara Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Achieved substantial enrollment in FORTIFI-HN01 pivotal trial in 1L R/M HPV-negative HNSCC; topline results from interim analysis expected in mid-2027 Enrolling FORTIFI-FLEX alternate dosing study; expect to have data by the time of potential U.S. approval in 1L R/M HPV-negative HNSCC Company to host conference call and webcast today, November 9, 2026 at 8:30 a.m. ET BOSTON, November 9, 2026 – Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to br" exhibit
Q3 FY2026 "Expect topline results from an interim analysis of the FORTIFI-HN01 pivotal trial in 1L R/M HPV-negative HNSCC in mid-2027." exhibit
Q3 FY2026 "Based on its current operating and development plans, the company expects that its existing cash, cash equivalents and marketable securities will fund operations into the first half of 2029." exhibit
Q2 FY2026 "Cohlhepp’s direction as the company prepares for the potential commercialization of ficerafusp alfa in first-line (1L) recurrent or metastatic (R/M) human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC), with topline data from an interim analysis of the FORTIFI-HN01 pivotal trial expected in mid-2027." exhibit
Q2 FY2026 "Jenna Cohen will be promoted from Chief Corporate Affairs Officer to Chief Business Officer, effective January 1, 2027." exhibit
Q2 FY2026 "Continued to enroll Phase 3 of the FORTIFI-HN01 pivotal trial in 1L R/M HPV-negative HNSCC and expect to be substantially enrolled by the end of the year to enable topline results from an interim analysis in mid-2027." exhibit
Q2 FY2026 "Based on its current operating and development plans, the company expects that its existing cash, cash equivalents and marketable securities will fund operations into the first half of 2029." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/BCAX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/BCAX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

BCAX earnings date badge

HTML

<a href="https://veritasdata.dev/company/BCAX/"><img src="https://veritasdata.dev/embed/BCAX.svg" alt="BCAX earnings date" width="240" height="56"></a>

Markdown

[![BCAX earnings date](https://veritasdata.dev/embed/BCAX.svg)](https://veritasdata.dev/company/BCAX/)

Script

<script async src="https://veritasdata.dev/embed/BCAX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/BCAX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.